Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting Illness01:18

Factors Affecting Illness

When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness, disability,...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Obsessive-Compulsive Disorder01:28

Obsessive-Compulsive Disorder

Obsessive-compulsive disorder (OCD) is a mental health condition characterized by recurrent obsessions, compulsions, or both, which consume significant time and interfere with daily functioning. Obsessions involve persistent, intrusive, and unwanted thoughts, images, or urges that evoke anxiety. Common examples include irrational fears of contamination or harm. Compulsions are repetitive behaviors or mental acts performed to reduce the anxiety caused by obsessions. For instance, individuals...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Odds Ratio01:09

Odds Ratio

The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early Efficacy and Exploratory Biomarker Data of Bel-sar in Patients with Intermediate-risk and High-risk Non-muscle-invasive Bladder Cancer.

European urology open science·2026
Same author

Radiogenomic analysis of muscle-invasive bladder cancer using CT-based texture analysis.

Bladder cancer (Amsterdam, Netherlands)·2026
Same author

Narrative Review of Potential Non-Surgical Treatments for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer.

Journal of clinical medicine·2026
Same author

Cigarette smoke induces FASN-dependent fatty acid metabolic rewiring to drive bladder cancer progression.

Cancer letters·2026
Same author

Leveraging untargeted metabolomics in combination with machine learning to uncover novel insights into bladder cancer.

Cancer & metabolism·2026
Same author

Enfortumab Vedotin plus Pembrolizumab as Perioperative Therapy.

The New England journal of medicine·2026
Same journal

Bladder cancer-from pathogenesis to prevention, 2008. Proceedings of an international consultation organized by the WHO Collaborating Center for Urologic Tumors. April 24-25, 2008. Stockholm, Sweden.

Scandinavian journal of urology and nephrology. Supplementum·2009
Same journal

The global burden of urinary bladder cancer.

Scandinavian journal of urology and nephrology. Supplementum·2008
Same journal

Bladder cancer: chemoprevention, complementary approaches and budgetary considerations.

Scandinavian journal of urology and nephrology. Supplementum·2008
Same journal

Screening for bladder cancer: theoretical and practical issues in considering the treated and untreated natural history of the various forms of the disease.

Scandinavian journal of urology and nephrology. Supplementum·2008
Same journal

Combining a molecular profile with a clinical and pathological profile: biostatistical considerations.

Scandinavian journal of urology and nephrology. Supplementum·2008
Same journal

How to combine the molecular profile with the clinicopathological profile of urothelial neoplastic lesions.

Scandinavian journal of urology and nephrology. Supplementum·2008
See all related articles

Related Experiment Videos

Occupational risk factors.

George L Delclos1, Seth P Lerner

  • 1Southwest Center for Occupational and Environmental Health, Division of Environmental and Occupational Health Sciences, The University of Texas School of Public Health, Houston, TX 77225, USA. George.Delclos@uth.tmc.edu

Scandinavian Journal of Urology and Nephrology. Supplementum
|December 5, 2008
PubMed
Summary
This summary is machine-generated.

Occupational exposures to chemical carcinogens contribute significantly to bladder cancer risk. While regulations have reduced workplace exposures in developed nations, developing countries face ongoing risks due to less stringent controls.

Related Experiment Videos

Area of Science:

  • Occupational Health
  • Environmental Epidemiology
  • Cancer Research

Background:

  • Occupational exposures to chemical carcinogens are a significant cause of bladder cancer, accounting for an estimated 20-27% of cases.
  • Individual susceptibility, carcinogen properties, exposure intensity, and workplace conditions influence bladder cancer risk.

Purpose of the Study:

  • To review the established link between occupational exposures and bladder cancer.
  • To highlight the disparity in regulatory control and its impact on worker health globally.

Main Methods:

  • Literature review of established associations between chemical carcinogens, occupations, industries, and bladder cancer.
  • Analysis of the impact of regulatory controls on occupational bladder cancer burden.

Main Results:

  • Regulatory controls in industrialized nations have successfully decreased workplace exposure to bladder carcinogens.
  • Developing countries may face increased occupational bladder cancer risks due to technology transfer and weaker regulatory enforcement.

Conclusions:

  • Occupational bladder cancer remains a significant public health concern, particularly in regions with less stringent worker protection.
  • Global disparities in regulatory enforcement necessitate targeted interventions to mitigate risks in developing countries.